EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

A comparative in vitro and in vivo analysis of the impact of copper substitution on the cytocompatibility, osteogenic, and angiogenic properties of a borosilicate bioactive glass

Linn Anna Fiehn iD, Elke Kunisch, Merve Saur, Marcela Arango-Ospina, Christian Merle, Sébastien Hagmann, Adrian Stiller, Leena Hupa, Hana Kaňková, Dagmar Galusková, Tobias Renkawitz, Aldo R Boccaccini und 1 weitere

Journal of Biomedical Materials Research Part A · 2024

DOI: 10.1002/jbm.a.37721 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Biomedical Materials Research Part A, 2024. Verfasst von Linn Anna Fiehn und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Copper, Osteogenesis, Mesenchymal Stem Cells, Neovascularization, Physiologic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union's Horizon 2020 Research and Innovation Program, VEGA 1/0191/20 project, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 0106‐B1‐bioactive glass (BG) composition (in wt %: 37.5 SiO 2 , 22.6 CaO, 5.9 Na 2 O, 4.0 P 2 O 5 , 12.0 K 2 O, 5.5 MgO, and 12.5 B 2 O 3 ) has demonstrated favorable processing properties and promising bone regeneration potential. The present study aimed to evaluate the biological effects of the incorporation of highly pro‐angiogenic copper (Cu) in 0106‐B1‐BG in vitro using human bone marrow‐derived mesenchymal stromal cells (BMSCs) as well as its in vivo potential for bone regeneration. CuO was added to 0106‐B1‐BG in exchange for CaO, resulting in Cu‐doped BG compositions containing 1.0, 2.5 and 5.0 wt % CuO (composition in wt %: 37.5 SiO 2 , 21.6/ 20.1/17.6 CaO, 5.9 Na 2 O, 4.0 P 2 O 5 , 12.0 K 2 O, 5.5 MgO, 12.5 B 2 O 3 , and 1.0/ 2.5/ 5.0 CuO). In vitro, the BGs' impact on the viability, proliferation, and growth patterns of BMSCs was evaluated. Analyses of protein secretion, matrix formation, and gene expression were used for the assessment of the BGs' influence on BMSCs regarding osteogenic differentiation and angiogenic stimulation. The presence of Cu improved cytocompatibility, osteogenic differentiation, and angiogenic response when compared with unmodified 0106‐B1‐BG in vitro. In vivo, a critical‐size femoral defect in rats was filled with scaffolds made from BGs. Bone regeneration was evaluated by micro‐computed tomography. Histological analysis was performed to assess bone maturation and angiogenesis. In vivo effects regarding defect closure, presence of osteoclastic cells or vascular structures in the defect were not significantly changed by the addition of Cu compared with undoped 0106‐B1‐BG scaffolds. Hence, while the in vitro properties of the 0106‐B1‐BG were significantly improved by the incorporation of Cu, further evaluation of the BG composition is necessary to transfer these effects to an in vivo setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperOsteogenesisMesenchymal Stem CellsNeovascularization, PhysiologicAnimalsHumansMaleGlassRatsSilicatesMaterials TestingBiocompatible MaterialsCell ProliferationRats, Sprague-DawleyCell DifferentiationBone Regeneration

Stichwörter der Autor:innen

angiogenesisbioactive glassbone defect regenerationboroncoppermesenchymal stromal cellsosteogenesis

Substanzen

CopperSilicatesBiocompatible Materials

Autor:innen und Institutionen

  • Department of Orthopaedics, Heidelberg University Hospital, Heidelberg, Germany.
  • Institute of Biomaterials, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Johan Gadolin Process Chemistry Centre, Åbo Akademi University, Turku, Finland.
  • Centre for Functional and Surface Functionalized Glass, Alexander Dubček University of Trenčín, Trenčín, Slovakia.

ORCID-Profile: Linn Anna Fiehn, Fabian Westhauser

Förderung

  • European Union's Horizon 2020 Research and Innovation Program
  • VEGA 1/0191/20 project
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Fiehn, L. A., Kunisch, E., Saur, M., Arango-Ospina, M., Merle, C., Hagmann, S., Stiller, A., Hupa, L., Kaňková, H., Galusková, D., Renkawitz, T., Boccaccini, A. R., & Westhauser, F. (2024). A comparative in vitro and in vivo analysis of the impact of copper substitution on the cytocompatibility, osteogenic, and angiogenic properties of a borosilicate bioactive glass. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37721

Vancouver

Fiehn LA, Kunisch E, Saur M, Arango-Ospina M, Merle C, Hagmann S, et al. A comparative in vitro and in vivo analysis of the impact of copper substitution on the cytocompatibility, osteogenic, and angiogenic properties of a borosilicate bioactive glass. Journal of Biomedical Materials Research Part A. 2024. doi:10.1002/jbm.a.37721

BibTeX
@article{Fiehn2024,
  author = {Fiehn, Linn Anna and Kunisch, Elke and Saur, Merve and Arango-Ospina, Marcela and Merle, Christian and Hagmann, Sébastien and Stiller, Adrian and Hupa, Leena and Kaňková, Hana and Galusková, Dagmar and Renkawitz, Tobias and Boccaccini, Aldo R and Westhauser, Fabian},
  title = {A comparative in vitro and in vivo analysis of the impact of copper substitution on the cytocompatibility, osteogenic, and angiogenic properties of a borosilicate bioactive glass},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2024},
  doi = {10.1002/jbm.a.37721}
}
Kostenlos starten →